These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32106338)

  • 1. Reevaluation of platelet function in chronic immune thrombocytopenia: impacts of platelet size, platelet-associated anti-αIIbβ3 antibodies and thrombopoietin receptor agonists.
    Nishiura N; Kashiwagi H; Akuta K; Hayashi S; Kato H; Kanakura Y; Tomiyama Y
    Br J Haematol; 2020 May; 189(4):760-771. PubMed ID: 32106338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia.
    Haselboeck J; Kaider A; Pabinger I; Panzer S
    Thromb Haemost; 2013 Apr; 109(4):676-83. PubMed ID: 23389750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
    Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
    Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim.
    Al-Samkari H; Van Cott EM; Kuter DJ
    Ann Hematol; 2019 Mar; 98(3):581-588. PubMed ID: 30446804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia.
    Alvarez Román MT; Fernández Bello I; Arias-Salgado EG; Rivas Pollmar MI; Jiménez Yuste V; Martín Salces M; Butta NV
    Thromb Haemost; 2014 Jul; 112(1):65-72. PubMed ID: 24500066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function and bleeding at different phases of childhood immune thrombocytopenia.
    Ignatova AA; Suntsova EV; Pshonkin AV; Martyanov AA; Ponomarenko EA; Polokhov DM; Fedorova DV; Voronin KA; Kotskaya NN; Trubina NM; Krasilnikova MV; Uzueva SS; Serkova IV; Ovsyannikova GS; Romanova KI; Hachatryan LA; Kalinina II; Matveev VE; Korsantiya MN; Smetanina NS; Evseev DA; Sadovskaya MN; Antonova KS; Khoreva AL; Zharkov PA; Shcherbina A; Sveshnikova AN; Maschan AA; Novichkova GA; Panteleev MA
    Sci Rep; 2021 Apr; 11(1):9401. PubMed ID: 33931737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet Apoptosis and PAI-1 are Involved in the Pro-Coagulant State of Immune Thrombocytopaenia Patients Treated with Thrombopoietin Receptor Agonists.
    Justo Sanz R; Monzón Manzano E; Fernández Bello I; Teresa Álvarez Román M; Martín Salces M; Rivas Pollmar MI; Jiménez Yuste V; Butta NV
    Thromb Haemost; 2019 Apr; 119(4):645-659. PubMed ID: 30743272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin and its receptor expression in pediatric patients with chronic immune thrombocytopenia.
    Li S; Shao J; Xia M; Zhang N; Yang J; Li H; Jiang H
    Hematology; 2018 Aug; 23(7):433-438. PubMed ID: 29313460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
    Kuter DJ
    Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura.
    Suntsova EV; Demina IM; Ignatova AA; Ershov NM; Trubina NM; Dobrynina J; Serkova IV; Supik ZS; Orekhova EV; Hachatryan LA; Kotskaya NN; Pshonkin AV; Maschan AA; Novichkova GA; Panteleev MA
    Int J Hematol; 2017 Jun; 105(6):841-848. PubMed ID: 28271416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
    Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
    Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.
    Erhardt JA; Erickson-Miller CL; Aivado M; Abboud M; Pillarisetti K; Toomey JR
    Exp Hematol; 2009 Sep; 37(9):1030-7. PubMed ID: 19631713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
    Makar RS; Zhukov OS; Sahud MA; Kuter DJ
    Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relativity study of thrombopoietin and chronic idiopathic thrombocytopenic purpura].
    Liao X; Wang Y; Deng C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):473-5. PubMed ID: 11758228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.
    Agnelli Giacchello J; Valeri F; Boccadoro M; Borchiellini A
    Eur J Haematol; 2018 Mar; 100(3):304-307. PubMed ID: 29243329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia.
    Nazy I; Kelton JG; Moore JC; Clare R; Horsewood P; Smith JW; Ivetic N; D'Souza V; Li N; Arnold DM
    Br J Haematol; 2018 Apr; 181(2):234-241. PubMed ID: 29532903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic changes by thrombopoietin-receptor agonists in immune thrombocytopenia patients.
    van Dijk WEM; Brandwijk ON; Heitink-Polle KMJ; Schutgens REG; van Galen KPM; Urbanus RT
    Blood Rev; 2021 May; 47():100774. PubMed ID: 33213987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice.
    Iino M; Sakamoto Y; Sato T
    Int J Hematol; 2020 Aug; 112(2):159-168. PubMed ID: 32476083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.